Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth-Reference-Cited by-同舟云学术

Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth

Published:2019-03-18 Issue:4 Volume:11 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Thilakasiri Pathum¹,Huynh Jennifer¹,Poh Ashleigh R¹,Tan Chin Wee²,Nero Tracy L³⁴,Tran Kelly¹,Parslow Adam C¹⁵,Afshar‐Sterle Shoukat¹,Baloyan David¹,Hannan Natalie J⁶,Buchert Michael¹,Scott Andrew Mark¹⁵⁷,Griffin Michael DW⁴,Hollande Frederic⁸,Parker Michael W³⁴,Putoczki Tracy L²,Ernst Matthias¹^ORCID,Chand Ashwini L¹^ORCID

Affiliation:

1. Olivia Newton‐John Cancer Research Institute School of Cancer Medicine La Trobe University Heidelberg Vic. Australia

2. The Walter and Eliza Hall Institute Melbourne Vic. Australia

3. ACRF Rational Drug Discovery Centre St Vincent's Institute Melbourne Vic. Australia

4. Department of Biochemistry and Molecular Biology Bio21 Institute University of Melbourne Melbourne Vic. Australia

5. Department of Molecular Imaging and Therapy Austin Health Melbourne Vic. Australia

6. Department of Obstetrics and Gynaecology University of Melbourne Melbourne Vic. Australia

7. Department of Medicine University of Melbourne Melbourne Vic. Australia

8. Department of Clinical Pathology University of Melbourne Centre for Cancer Research Victorian Comprehensive Cancer Centre University of Melbourne Melbourne Vic. Australia

Funder

National Health and Medical Research Council

Australian Research Council

Cancer Australia

Ludwig Institute for Cancer Research

Cure Brain Cancer Foundation

Cancer Council Victoria

Publisher

EMBO

Subject

Molecular Medicine

Link